BioScience Health Innovations, Inc.
BHIC
$4.00
-$32.04-88.90%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.80K | 457.70K | 426.80K | 10.00K | 56.20K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -331.70K | -172.70K | -98.50K | -60.30K | -4.00K |
| Cash from Operations | -340.40K | 285.00K | 328.30K | -50.30K | 52.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -16.10K | -30.00K | -19.00K | -7.00K |
| Cash from Investing | 0.00 | -16.10K | -30.00K | -19.00K | -7.00K |
| Total Debt Issued | 1.03M | 802.10K | 589.50K | 270.10K | 274.30K |
| Total Debt Repaid | -850.00K | -800.00K | -522.00K | -326.50K | -255.20K |
| Issuance of Common Stock | -- | -- | -- | 455.00K | 125.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 180.50K | 2.10K | 67.50K | 398.60K | 144.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -160.00K | 271.10K | 365.80K | 329.30K | 189.30K |